Patients' medical and psychosocial experiences after detection of a CDH1 variant with multigene panel testing

Jada G. Hamilton, Jessica M. Long, Amanda C. Brandt, Jamie Brower, Heather Symecko, Erin E. Salo-Mullen, Stephanie N. Christian, Tricia Harstad, Fergus J. Couch, Judy E. Garber, Kenneth Offit, Mark E. Robson, Susan M. Domchek

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

PURPOSE Germline CDH1 pathogenic variants (PV) are associated with hereditary diffuse gastric cancer and lobular breast cancer. Although prevalence of CDH1 PV is low in the general population, detection of these variants is increasing with the growing use of multigene panel testing. Little is known about the experiences of individuals tested for CDH1 variants in the multigene panel testing era. METHODS Participants recruited from the Prospective Registry of Multiplex Testing completed a cross-sectional self-report survey regarding CDH1 genetic testing experiences, medical management, and psychosocial adaptation. RESULTS Discordance existed in interpretations of CDH1 results; 13.3% of cases had disagreements in variant classifications among commercial laboratories, and 21.4% had disagreements between participant self-report and ClinVar classification. Survey data were available from 57 individuals reporting either PV (n = 16) or variants of uncertain significance (VUS; n = 41). Those with PV were more likely than those with VUS to report receiving a recommendation for prophylactic gastrectomy, although only 40.0% of those with PV received this recommendation. Participants with VUS were less satisfied with their health care providers' knowledge and reported less CDH1 knowledge, distress, and worry about discrimination. Participants with PV perceived greater breast cancer risks, but similar gastric cancer risks, as those with VUS. CONCLUSION Few individuals with CDH1 PV report receiving recommendations for prophylactic gastrectomy, and no differences in perceived gastric cancer risk were observed based on participants' CDH1 results, suggesting serious unmet informational needs.

Original languageEnglish (US)
Pages (from-to)1-14
Number of pages14
JournalJCO Precision Oncology
Issue number3
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Patients' medical and psychosocial experiences after detection of a CDH1 variant with multigene panel testing'. Together they form a unique fingerprint.

  • Cite this

    Hamilton, J. G., Long, J. M., Brandt, A. C., Brower, J., Symecko, H., Salo-Mullen, E. E., Christian, S. N., Harstad, T., Couch, F. J., Garber, J. E., Offit, K., Robson, M. E., & Domchek, S. M. (2019). Patients' medical and psychosocial experiences after detection of a CDH1 variant with multigene panel testing. JCO Precision Oncology, (3), 1-14. https://doi.org/10.1200/PO.18.00300